All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • VQW-765Phase 31 trial

    Vanda Pharmaceuticals · Social Anxiety Disorder (SAD)

  • VSA012Phase 31 trial

    Bisirna Therapeutics (Suzhou) Co., Ltd. · Paroxysmal Nocturnal Hemoglobinuria, PNH

  • VVN001Phase 31 trial

    VivaVision Biotech, Inc · Dry Eye

  • VX-017Phase 31 trial

    Vertex Pharmaceuticals · Diabetes Mellitus, Type 1, Impaired Hypoglycemic Awareness, Severe Hypoglycemia

  • VYD222pemivibartPhase 31 trial

    Invivyd, Inc. · COVID-19, SARS-CoV-2

  • VYD2311-MDPhase 31 trial

    Invivyd, Inc. · COVID-19

  • VYD2311-SDPhase 31 trial

    Invivyd, Inc. · COVID-19

  • W2505Phase 31 trial

    GL Pharm Tech Corporation · Erectile Dysfunctions

  • W2505-P1Phase 31 trial

    GL Pharm Tech Corporation · Erectile Dysfunctions

  • W2505-P2Phase 31 trial

    GL Pharm Tech Corporation · Erectile Dysfunctions

  • W2505-RPhase 31 trial

    GL Pharm Tech Corporation · Erectile Dysfunctions

  • XKH004Phase 31 trial

    Zhejiang Kanova Biopharmaceutical Co., LTD · Phase III

  • XTR00499mTechnicium Sestamibi, Procedure: Coronary angiographyPhase 31 trial

    Sinotau Pharmaceutical Group · Coronary Artery Disease(CAD)

  • XTR006[18F]MK 6240, FlorquinitauPhase 31 trial

    Sinotau Pharmaceutical Group · Alzheimer Disease, Neurofibrillary Tangle

  • XY0206Phase 31 trial

    Shijiazhuang Yiling Pharmaceutical Co. Ltd · Acute Myeloid Leukemia With FLT3/ITD Mutation

  • YHP2401Phase 31 trial

    Yuhan Corporation · Acute Bronchitis

  • YHR2402Phase 31 trial

    Yuhan Corporation · Acute Bronchitis

  • YHR2403Phase 31 trial

    Yuhan Corporation · Acute Bronchitis

  • YK-1169Phase 31 trial

    Nanjing Yoko Biomedical Co., Ltd. · Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)

  • YK-209APhase 31 trial

    Suzhou Puhe Pharmaceutical Technology Co., LTD · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  • YZJ-1139Phase 31 trial

    Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Insomnia Disorder

  • ZelpultideAT-100, rhSP-DPhase 31 trial

    Airway Therapeutics, Inc. · Bronchopulmonary Dysplasia

  • ZovegalisibPhase 31 trial

    Relay Therapeutics, Inc. · PIK3CA Mutation, HER2- Negative Breast Cancer, Hormone Receptor Positive Tumor

  • ZX-7101APhase 31 trial

    Nanjing Zenshine Pharmaceuticals · Respiratory Viral Infection

  • MK-4830Phase 210 trials

    Merck & Co. · Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma, Esophageal Squamous Cell Carcinoma

  • SI-B003Phase 210 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Non-small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck

  • NM8074Phase 28 trials

    NovelMed Therapeutics · Paroxysmal Nocturnal Hemoglobinuria, Dermatomyositis, PNH - Paroxysmal Nocturnal Hemoglobinuria

  • rapcabtagene autoleucelYTB323Phase 28 trials

    Novartis · Lupus Nephritis, Rheumatoid Arthritis (RA) and Sjögren's Disease (SjD), ANCA Associated Vasculitis (AAV)

  • SHR-9839Phase 28 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Advanced Solid Tumors, Advanced Esophageal Squamous Cell Carcinoma, Non-small Cell Lung Cancer (NSCLC)

  • UC-MSCRY_SW01 cell, Human umbilical cord mesenchymal stem cellsPhase 28 trials

    Jiangsu Renocell Biotech Company · Acute Respiratory Distress Syndrome, Lupus Nephritis, Spinocerebellar Ataxia Type 1

  • AK139Phase 26 trials

    Akeso · Asthma, Moderate-to-Severe Atopic Dermatitis, Chronic Spontaneous Urticaria

  • BL-M08D1Phase 26 trials

    Sichuan Baili Pharmaceutical Co., Ltd. · Solid Tumors, Gastrointestinal Tumors, Diffuse Large B-Cell Lymphoma

  • Peg-IFN-αpegylated interferonPhase 26 trials

    Brii Biosciences Limited · Chronic Hepatitis B, Chronic Hepatitis B Virus (HBV) Infection, Hepatitis B, Chronic

  • RO7247669Tobemstomig, RG6139Phase 26 trials

    Roche (Genentech) · Solid Tumors, Metastatic Melanoma, Non-small Cell Lung Cancer

  • SKB571Phase 26 trials

    Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Lung Cancer (Non-Small Cell), Non-Small Cell Lung Cancer, Gastrointestinal Tumors

  • VibostolimabMK-7684Phase 26 trials

    Merck & Co. · Melanoma, Carcinoma, Non-Small-Cell Lung, Metastatic Urothelial Carcinoma

  • brivekimigSAR442970Phase 25 trials

    Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus

  • Dual-target CAR-NK cellsEB-DT-CAR-NK, Essen Biotech Dual-Target CAR-NKPhase 25 trials

    Beijing Biotech · HER2-positive Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer (Locally Advanced or Metastatic)

  • EvorpaceptALX148Phase 25 trials

    ALX Oncology Inc. · Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Breast Cancer, Metastatic

  • GFH276Phase 25 trials

    Genfleet Therapeutics (Shanghai) Inc. · RAS Mutation, Pancreatic Cancer, Non-small Cell Lung Cancer (NSCLC)

  • KAE609CipargaminPhase 25 trials

    Novartis · Uncomplicated Plasmodium Falciparum Malaria, Severe Malaria

  • ONO-1110Phase 25 trials

    Ono Pharmaceutical Co., Ltd. · Fibromyalgia, Social Anxiety Disorder (SAD), Major Depressive Disorder (MDD

  • PalacaparibAZD9574Phase 25 trials

    AstraZeneca · Metastatic Prostate Cancer, Ovarian Cancer, Endometrial Cancer

  • SHR-1139Phase 25 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Moderate to Severe Plaque Psoriasis, Palmoplantar Pustulosis of Adults, Pyoderma Gangrenosum

  • SHR-1826Phase 25 trials

    Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Non-small Cell Lung Cancer (NSCLC), Non-Small Cell Lung Cancer, Resectable Non-small Cell Lung Cancer

  • SHR-2173Phase 25 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Generalized Myasthenia Gravis, Active Lupus Nephritis, Primary IgA Nephropathy

  • StromaForteHuman Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product, MSCsPhase 25 trials

    Cellcolabs Clinical LTD. · Cardiovascular Diseases, Frailty, Musculoskeletal Injury

  • zamtocabtagene autoleucelMB-CART2019.1Phase 25 trials

    Miltenyi Biomedicine GmbH · CAR T Cell Therapy, Mantle Cell Lymphoma (MCL), Multiple Sclerosis

  • Zelenectide pevedotinBT8009Phase 25 trials

    BicycleTx Limited · Breast Cancer, Non-Small Cell Lung Cancer, Advanced Solid Tumors

  • AB928Etrumadenant, ETRUMAPhase 24 trials

    Arcus Biosciences, Inc. · Lung Cancer, Advanced or Metastatic Non-Small-Cell Lung Cancer, Resectable Non-Small-Cell Lung Cancer

NewerPage 29 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.